✦ LIBER ✦

1401 POSTER DISCUSSION Choi Response Criteria for Prediction of Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapies

✍ Scribed by S. Potthast; V. Hess; N. Schmidt; T. Zumbrunn; G.M. Bongartz; C. Rothermundt

Book ID: 117661387
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 44 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(11)70894-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Choi response criteria for prediction of

Choi response criteria for prediction of survival in patients with metastatic renal cell carcinoma treated with anti-angiogenic therapies

✍ Noemi Schmidt, Viviane Hess, Thomas Zumbrunn, Christian Rothermundt… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 524 KB

Choi response criteria for early predict

Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

✍ van der Veldt, A A M; Meijerink, M R; van den Eertwegh, A J M; Haanen, J B A G; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 447 KB

1400 POSTER DISCUSSION Interest of CHOI

1400 POSTER DISCUSSION Interest of CHOI and Modified CHOI Criterion for Evaluation of Metastatic Renal Cell Carcinomas (mRCC) Patients Treated With Everolimus

✍ M. Lamuraqlia; S. Oudard; B. Escudier; A. Ravaud; F. Rolland; C. Chevreau; S. Ne 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

The Choi response criteria for inferior

The Choi response criteria for inferior vena cava tumor thrombus in renal cell carcinoma treated with targeted therapy

✍ Kwon, Taekmin; Lee, Jae-Lyun; Kim, Jeong Kon; You, Dalsan; Jeong, In Gab; Song, 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 587 KB

Clinical factors associated with outcome

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to

The association of clinical outcome to f

The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

✍ Mhd Y. Al-Marrawi, Brian I. Rini, Lauren C. Harshman, Georg Bjarnason… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 269 KB